Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer.
Saved in:
| Title: | Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer. |
|---|---|
| Authors: | Nalio Ramos R; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France., Missolo-Koussou Y; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France., Gerber-Ferder Y; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France., Bromley CP; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK., Bugatti M; Department of Pathology, University of Brescia, Brescia 25123, Italy., Núñez NG; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France., Tosello Boari J; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France., Richer W; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France., Menger L; PSL University, Institut Curie Research Center, INSERM U932, 75005 Paris, France., Denizeau J; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France., Sedlik C; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France., Caudana P; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France., Kotsias F; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France., Niborski LL; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France., Viel S; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France., Bohec M; PSL University, Institut Curie Research Center, Institut Curie Genomics of Excellence Platform, 75005 Paris, France., Lameiras S; PSL University, Institut Curie Research Center, Institut Curie Genomics of Excellence Platform, 75005 Paris, France., Baulande S; PSL University, Institut Curie Research Center, Institut Curie Genomics of Excellence Platform, 75005 Paris, France., Lesage L; PSL University, Institut Curie Hospital, Department of Pathology, 75005 Paris, France., Nicolas A; PSL University, Institut Curie Hospital, Department of Pathology, 75005 Paris, France., Meseure D; PSL University, Institut Curie Hospital, Department of Pathology, 75005 Paris, France., Vincent-Salomon A; PSL University, Institut Curie Hospital, Department of Pathology, 75005 Paris, France., Reyal F; PSL University, Institut Curie Hospital, Department of Surgery, 75005 Paris, France., Dutertre CA; Université Paris-Saclay, Institut Gustave Roussy, INSERM U1015, Villejuif, France., Ginhoux F; Université Paris-Saclay, Institut Gustave Roussy, INSERM U1015, Villejuif, France; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore., Vimeux L; University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, 75014 Paris, France., Donnadieu E; University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, 75014 Paris, France., Buttard B; INSERM, Sorbonne Université, Université de Paris, Centre de Recherche des Cordeliers, Laboratory of Integrative Cancer Immunology, Paris, France., Galon J; INSERM, Sorbonne Université, Université de Paris, Centre de Recherche des Cordeliers, Laboratory of Integrative Cancer Immunology, Paris, France., Zelenay S; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK., Vermi W; PSL University, Institut Curie Research Center, INSERM U932, 75005 Paris, France; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA., Guermonprez P; Université de Paris, Centre for Inflammation Research, CNRS ERL8252, INSERM1149, Paris, France., Piaggio E; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France., Helft J; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France. Electronic address: julie.helft@inserm.fr. |
| Source: | Cell [Cell] 2022 Mar 31; Vol. 185 (7), pp. 1189-1207.e25. Date of Electronic Publication: 2022 Mar 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
